ICU Medical ICUI Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue, Remaining Performance Obligation, Amount by Product | ||||||
| Equipment revenue | $50.94M+108% | $24.53M+20.6% | $20.34M+65.4% | $12.3M-38.9% | $20.11M+18.0% | |
| Government Grant Revenue | $4.77M-9.6% | $5.28M-9.0% | $5.8M-8.2% | $6.32M-7.6% | $6.83M-6.9% | |
| Other deferred revenue | $1.38M+54.8% | $888K+45.3% | $611K-31.3% | $890K-46.5% | $1.66M+5,447% | |
| Software revenue | $6.28M-1.3% | $6.36M+8.1% | $5.88M-11.8% | $6.67M-22.9% | $8.65M-22.9% | |
| Revenue by Product | ||||||
| Infusion Consumables | $278.28M-2.3% | $284.68M-0.1% | $285.09M+4.4% | $273.13M+2.6% | $266.23M-0.7% | |
| Infusion Systems | $179.6M+1.9% | $176.3M+1.4% | $173.91M+3.7% | $167.7M+0.8% | $166.3M-3.1% | |
| Vital Care | $72.35M-9.2% | $79.72M+2.2% | $77.99M-27.8% | $108.04M-37.3% | $172.18M-9.4% | |
| Revenue by Geography | ||||||
| Asia Pacific | $58.3M— | —— | $57.48M-1.6% | $58.4M-1.7% | $59.41M— | |
| UNITED STATES | $315.5M-3.0% | $325.31M+5.9% | $307.13M-8.4% | $335.43M-13.6% | $388.25M-6.1% | |
| Total property and equipment, cost by Geography | ||||||
| Asia Pacific | $27.26M-3.5% | $28.24M-2.0% | $28.8M-3.2% | $29.75M+8.7% | $27.37M-0.7% | |
| CANADA | $2.12M+6.9% | $1.98M+4.2% | $1.9M-0.8% | $1.92M+28.5% | $1.49M-71.7% | |
| COSTA RICA | $169.75M+0.6% | $168.68M+3.1% | $163.69M+1.9% | $160.68M+2.0% | $157.58M+0.9% | |
| CZECHIA | $9.54M-32.4% | $14.11M+1.3% | $13.93M+0.9% | $13.8M+9.8% | $12.58M+5.6% | |
| Europe | $11.58M+0.8% | $11.49M-0.7% | $11.56M-0.1% | $11.58M+7.6% | $10.77M-5.9% | |
| Foreign | $479.42M-0.1% | $479.94M+3.3% | $464.76M+2.3% | $454.1M+5.4% | $431.03M+1.4% | |
| ITALY | $35M-1.3% | $35.47M+1.4% | $34.98M+1.2% | $34.56M+11.2% | $31.09M+6.8% | |
| MEXICO | $128.97M+1.2% | $127.39M+4.0% | $122.52M+4.0% | $117.84M+4.9% | $112.38M+1.2% | |
| Other LATAM | $73.16M+3.0% | $71.05M+5.5% | $67.33M+5.1% | $64.06M+7.4% | $59.66M+7.6% | |
| SPAIN | $22.04M+2.4% | $21.53M+7.4% | $20.05M+0.7% | $19.91M+9.9% | $18.12M+5.7% | |
| UNITED STATES | $626.44M+1.4% | $617.79M-1.4% | $626.83M-0.3% | $628.67M+1.6% | $618.86M+1.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ICU Medical break its business down?
- ICU Medical (ICUI) reports revenue, remaining performance obligation, amount by product across 4 parts — Equipment revenue, Government Grant Revenue, Other deferred revenue and Software revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does ICU Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ICU Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.